Navigation Links
Skinvisible Appoints Dr. George Korkos to Its Advisory Board
Date:10/26/2007

Dr. Korkos' Expertise to Help Build New Opportunities

LAS VEGAS, Oct. 26 /PRNewswire-FirstCall/ -- As part of its strategy to continue to expand its product pipeline and pharmaceutical contacts, Skinvisible, Inc. (OTC Bulletin Board: SKVI) http://www.skinvisible.com, the developers of Invisicare(R), a patented polymer delivery system for topical skincare products, today announced the appointment of George J. Korkos, M.D. to its Advisory Board. Dr. Korkos is a nationally renowned plastic and reconstructive surgeon and is also known for his business acumen.

(Logo: http://www.newscom.com/cgi-bin/prnh/20030416/LAW068LOGO

http://www.newscom.com/cgi-bin/prnh/20040503/INVISICARELOGO)

"We are pleased to have such a distinguished world-class plastic surgeon agree to contribute his medical and business expertise to Skinvisible as we continue to develop our polymer delivery technologies and new topical products for the global marketplace," said Mr. Terry Howlett, President / CEO of Skinvisible. "Dr. Korkos will be a great addition to our Board. He has the medical expertise, business experience, contacts and enthusiasm to assist us in bringing Skinvisible and our products in front of new companies, both in the medical/plastic surgery area and the investment community. He has ideas for new applications for our technology and will assist us in taking these products from concept to commercialization."

"I am pleased to be asked to serve on the Advisory Board of Skinvisible, Inc." said Dr. Korkos. "They have an exciting technology that I believe has many interesting applications in the medical field. The skincare industry is looking for new innovation to enhance their product lines and the Invisicare delivery technology does exactly that. I also like the fact that Skinvisible is dedicated to R&D and protecting their intellectual property at every turn; that's key in this industry."

Dr. Korkos received his degree from the Medical College of Wisconsin and did his plastic surgery residency at St. Louis University. He is currently the President of Plastic Surgery Associates in Milwaukee, Wisconsin and Blue Mound Surgery Center along with being an Associate Clinical Professor at the Medical College of Wisconsin. Recently Dr. Korkos was honored with the establishment of the first endowed chair at the Medical College of Wisconsin; The George J. Korkos Chair in Plastic Surgery. His business background is diverse. Along with sitting on Boards of emerging companies, Dr. Korkos has also served on the Board of a number of financial and investment institutions.

About Skinvisible Pharmaceuticals, Inc.

Skinvisible Pharmaceuticals, a wholly owned subsidiary of Skinvisible Inc., is a research-and-development company whose primary business objective is to license its proprietary formulations with Invisicare to pharmaceutical and cosmeceutical companies as well as assisting companies in revitalizing or enhancing their existing skin care products. Skinvisible receives a combination of research and development fees, upfront license fees, and ongoing royalties for the life of the patent. http://www.skinvisible.com

About Invisicare(R)

Invisicare is a patented polymer delivery system developed to hold active ingredients topically on the skin for extended periods of time. A key benefit is that Invisicare is non-occlusive on the skin, allowing normal skin respiration and perspiration. The Company has developed a portfolio of topical products using Invisicare for the dermatology and cosmeceutical industries. http://www.invisicare.com

Forward-Looking Statements

This press release contains 'forward looking' statements within the meaning of Section 21A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbors created thereby. Such statements involve certain risks and uncertainties associated with an emerging company. Actual results could differ materially from those projected in the forward looking statements as a result of risk factors discussed in Skinvisible, Inc. reports on file with the U.S. Securities and Exchange Commission (including, but not limited to, a report on Form 10Q for the quarter ending June 30, 2007)


'/>"/>
SOURCE Skinvisible, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. George Bush pledges 200 million dollars for AIDS relief
2. Arsenic May Have Been Responsible For The Madness Of King George III Of England
3. Study Unveils New Insight To The Madness Of King George III
4. Investigation into the Poor Hospital Facility That Led To the Death of George Cook
5. Georgetown University Heads Alternative Tobacco Project
6. WHO lifts HongKong advisory
7. FDA Issues Public Health Advisory on Tysabri, a New Drug for MS
8. Doctors Said – ‘Stop Pressurising NHS Advisory Bod’
9. Mercks Pain Reliever Arcoxia Rejected by US Federal Advisory Panel
10. FDA Advisory Against Anti-depressants to Be Expanded to Cover Young Adults too
11. FDA Advisory Against Anti-depressants to Be Expanded to Cover Young Adults too
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Aliso Viejo, California (PRWEB) , ... June 26, 2016 , ... ... for Final Cut Pro X. , "Film editors can give their videos a whole ... artistically," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Levels ...
(Date:6/26/2016)... Orion, Clarkston, Michigan (PRWEB) , ... June 26, ... ... with respect to fertility once they have been diagnosed with endometriosis. These women ... intercourse but they also require a comprehensive approach that can help for preservation ...
(Date:6/25/2016)... ... , ... The temporary closing of Bruton Memorial Library on June 21 due to a possible ... often overlooked aspect of head lice: the parasite’s ability to live away from a human ... but a necessary one in the event that lice have simply gotten out of control. ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern ... Laude and his M.D from the David Geffen School of Medicine at UCLA. He ... Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program ...
(Date:6/25/2016)... ... , ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter ... bar too high can result in disappointment, perhaps even self-loathing. However, those who set ... , Research from PsychTests.com reveals that behind the tendency to set low ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Collagen Matrix, Inc., ("Collagen Matrix") ... manufacturing of collagen and mineral based medical devices ... Bill Messer has joined the company ... leverage the growing portfolio of oral surgery, neurosurgery, ... Bill joins the Collagen Matrix executive team as ...
(Date:6/24/2016)... , June 24, 2016   Bay ... Rehabilitation Network,s Dean Center for Tick Borne ... Medicine and Rehabilitation, MIT Hacking Medicine, University of ... Innovation, today announced the five finalists of ... Lyme disease.  More than 100 scientists, clinicians, researchers, ...
(Date:6/24/2016)... , June 24, 2016 ... of the "Structural Electronics 2015-2025: Applications, Technologies, ... In-Mold Electronics, Smart Skin, ... Photovoltaics Structural electronics involves electronic ... load-bearing, protective structures, replacing dumb structures such as ...
Breaking Medicine Technology: